Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...
Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and ...
This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...
ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...
Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on ...
These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...
Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...
2d
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
The guidance, along with comments from FDA Commissioner Marty Makary, adds to existing policy that classifies low-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback